Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v3.20.2
Segment Disclosures
 9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Segment Disclosures Segment Disclosures
 
The Company has two reportable segments: EksoHealth (also referred to as the medical devices segment) and EksoWorks (also referred to as the industrial devices segment). The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The reportable segments are each managed separately because they serve distinct markets.
 
The Company evaluates performance and allocates resources based on segment gross profit margin. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
  EksoHealth EksoWorks Total
Three months ended September 30, 2020      
Revenue $ 2,739  $ 158  $ 2,897 
Cost of revenue 989  95  1,084 
Gross profit $ 1,750  $ 63  $ 1,813 
Three months ended September 30, 2019      
Revenue $ 2,999  $ 320  $ 3,319 
Cost of revenue 1,297  272  1,569 
Gross profit $ 1,702  $ 48  $ 1,750 


EksoHealth EksoWorks Total
Nine Months Ended September 30, 2020
Revenue $ 6,015  $ 613  $ 6,628 
Cost of revenue 2,466  453  2,919 
Gross profit $ 3,549  $ 160  $ 3,709 
Nine Months Ended September 30, 2019
Revenue $ 8,661  $ 1,536  $ 10,197 
Cost of revenue 3,932  1,356  5,288 
Gross profit $ 4,729  $ 180  $ 4,909 
Geographic information for revenue based on location of customers is as follows:
  Three Months Ended September 30, Nine Months Ended September 30,
  2020 2019 2020 2019
United States $ 1,926  $ 1,941  $ 4,813  $ 6,669 
All Other 971  1,378  1,815  3,528 
  $ 2,897  $ 3,319  $ 6,628  $ 10,197